Product Information
CEFDINIR 125 MG/5 ML SUSP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1168 per ML under NDC 68180072204. Its NADAC has been published 299 times since Oct 7, 2020.
Strength
125 mg/5mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180072204
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CEFDINIRApproval Type
Generic (ANDA)
FDA Application
ANDA065259On Market Since
5/31/2006
Pharmacological Classes
Price Statistics
The NADAC for CEFDINIR 125 MG/5 ML SUSP has been published 299 times since Oct 7, 2020, and over the history we have for it it has declined 44.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1168 per ML |
|---|---|
| All-time high | $0.2103 (Oct 14, 2020) |
| All-time low | $0.1125 (Apr 17, 2024) |
| 52-week high | $0.1263 |
| 52-week low | $0.1168 |
| Median price | $0.1429 |
| Average price | $0.1449 |
| Largest weekly change | +33.3% (Jun 19, 2024) |
| Weeks tracked | 299 |
| Tracking since | Oct 7, 2020 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFDINIR 125 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFDINIR 125 MG/5 ML SUSP, manufactured by Lupin Pharmaceuticals Inc., is $0.1168 per ML (NDC 68180072204), effective Jun 24, 2026.
How has the price of CEFDINIR 125 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFDINIR 125 MG/5 ML SUSP has declined 44.5%. It has been tracked across 299 weekly CMS publications since Oct 7, 2020.
What are the highest and lowest recorded NADAC prices for CEFDINIR 125 MG/5 ML SUSP?
Since Oct 7, 2020, the NADAC for CEFDINIR 125 MG/5 ML SUSP has ranged from a low of $0.1125 (Apr 17, 2024) to a high of $0.2103 (Oct 14, 2020), with a median of $0.1429 per ML.
Are there cheaper alternatives to CEFDINIR 125 MG/5 ML SUSP?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CEFDINIR 125 MG/5 ML SUSP, is $0.0983 per ML — about 16% below CEFDINIR 125 MG/5 ML SUSP.
Who manufactures CEFDINIR 125 MG/5 ML SUSP?
CEFDINIR 125 MG/5 ML SUSP (NDC 68180072204) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification